WallStreetZenWallStreetZen

NASDAQ: ZIMV
Zimvie Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Analyst price target for ZIMV

Based on 2 analysts offering 12 month price targets for Zimvie Inc.
Min Forecast
$16.00+3.29%
Avg Forecast
$16.00+3.29%
Max Forecast
$16.00+3.29%

Should I buy or sell ZIMV stock?

Based on 2 analysts offering ratings for Zimvie Inc.
Sell
Strong Buy
0 analysts 0%
Buy
0 analysts 0%
Hold
1 analysts 50%
Sell
0 analysts 0%
Strong Sell
1 analysts 50%

Be the first to know when Wall Street analysts revise their ZIMV stock forecasts and price targets.

ZIMV stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2024-03-05
lockedlocked$00.00+00.00%2023-12-20

1 of 1

Forecast return on equity

Is ZIMV forecast to generate an efficient return?
Company
N/A
Industry
20.3%
Market
28.28%

Forecast return on assets

Is ZIMV forecast to generate an efficient return on assets?
Company
N/A
Industry
10.65%

ZIMV revenue forecast

What is ZIMV's revenue in the next 2 years based on estimates from 1 analyst?
Avg 1 year Forecast
$852.2M+86.31%
Avg 2 year Forecast
$851.2M+86.08%
ZIMV's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

ZIMV revenue growth forecast

How is ZIMV forecast to perform vs Medical Devices companies and vs the US market?
Company
86.31%
Industry
10.69%
Market
13.29%
ZIMV's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
ZIMV's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

ZIMV vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
ZIMV$15.49$16.00+3.29%Sell
PACB$1.56$7.77+398.27%Buy
MXCT$3.96$8.67+118.86%Strong Buy
NPCE$14.00$17.00+21.43%Strong Buy
NVRO$12.27$17.73+44.47%Hold
View Top Medical Device Stocks

Zimvie Stock Forecast FAQ

Is Zimvie Stock a good buy in 2024, according to Wall Street analysts?

The consensus among 2 Wall Street analysts covering (NASDAQ: ZIMV) stock is to Sell ZIMV stock.

Out of 2 analysts, 0 (0%) are recommending ZIMV as a Strong Buy, 0 (0%) are recommending ZIMV as a Buy, 1 (50%) are recommending ZIMV as a Hold, 0 (0%) are recommending ZIMV as a Sell, and 1 (50%) are recommending ZIMV as a Strong Sell.

If you're new to stock investing, here's how to buy Zimvie stock.

What is ZIMV's revenue growth forecast for 2024-2025?

(NASDAQ: ZIMV) Zimvie's forecast annual revenue growth rate of 86.31% is forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 10.69%, and it is also forecast to beat the US market's average forecast revenue growth rate of 13.29%.

Zimvie's revenue in 2024 is $457,433,000.On average, 1 Wall Street analysts forecast ZIMV's revenue for 2024 to be $23,081,930,949, with the lowest ZIMV revenue forecast at $23,081,930,949, and the highest ZIMV revenue forecast at $23,081,930,949.

In 2025, ZIMV is forecast to generate $23,052,951,242 in revenue, with the lowest revenue forecast at $23,052,951,242 and the highest revenue forecast at $23,052,951,242.

What is ZIMV's forecast return on assets (ROA) for 2024-2025?

(NASDAQ: ZIMV) forecast ROA is N/A, which is lower than the forecast US Medical Devices industry average of 10.65%.

What is ZIMV's Price Target?

According to 2 Wall Street analysts that have issued a 1 year ZIMV price target, the average ZIMV price target is $16.00, with the highest ZIMV stock price forecast at $16.00 and the lowest ZIMV stock price forecast at $16.00.

On average, Wall Street analysts predict that Zimvie's share price could reach $16.00 by Mar 5, 2025. The average Zimvie stock price prediction forecasts a potential upside of 3.29% from the current ZIMV share price of $15.49.

What is ZIMV's forecast return on equity (ROE) for 2024-2025?

(NASDAQ: ZIMV) forecast ROE is N/A, which is considered weak.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.